tirzepatide to retatrutide dosing Dosage & Guide: Titration, Missed Doses, Taper YOUR MOUNJARO & RETATRUTIDE WEEKLY

1 In studies, most nausea, diarrhea and vomiting occurred when people increased their dose but the effects generally decreased over time

Reports of alopecia (6.9% vs 0.3%) were higher in patients who received 50 mg oral semaglutide weekly than in those on placebo, but only 0.2% of patients on 2.4 mg of subcutaneous semaglutide reported alopecia vs 0.5% of those on placebo

Mild nausea often resolves within a couple of weeks, while some individuals may experience intermittent symptoms for a longer period

Increase gradually over 2 to 3 weeks

The FDA has ceased compounded tirzepatide following the stabilization of the national supply of GLP-1 medications, which includes tirzepatide